GnRH antagonist
Degarelix clinical trials
Answer
Degarelix has 187 registered trials: 51 running, 84 completed, 19 stopped early. 57 posted results.
Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT01630967 Trial register | Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Can | withdrawn before enrolling anyone | - | 2012-06-28 | - |
| NCT04989946 Trial register | Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer | running, but no longer enrolling | - | 2021-08-04 | - |
| NCT03070886 Trial register | Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery | running, but no longer enrolling | - | 2017-03-06 | - |
| NCT07335796 Trial register | A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer | running, but no longer enrolling | - | 2026-01-13 | - |
| 2023-509494-23-00 Trial register | DARIUS : A RANDOMIZED NON-COMPARATIVE PHASE II MULTICENTRIC TRIAL ON SHORT TERM DAROLUTAMIDE (ODM-201) CONCOMITANT TO RADIATION THERAPY FOR PATIENTS WITH INTERM | Not stated | 2 | - | - |
| 2025-521859-23-00 Trial register | A phase Ib/II open-label, multi-center study of the DNA protein kinase inhibitor AMO959 with lutetium (177Lu) vipivotide tetraxetan (AAA617) in combination with | Not stated | 1/2 | - | - |
| NCT02005887 Trial register | TRial on the Endocrine Activity of Neoadjuvant Degarelix | completed | - | 2013-12-09 | Posted |
| NCT04633252 Trial register | A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant | currently recruiting participants | - | 2020-11-17 | - |
| 2022-503040-41-00 Trial register | An international prospective open-label, multi-center, randomized, non-comparative phase II study of lutetium [177Lu] vipivotide tetraxetan (AAA617) alone and l | Not stated | 2 | - | - |
| NCT05501704 Trial register | ETHAN - ET for Male BC | currently recruiting participants | - | 2022-08-15 | - |
| 2024-517285-41-00 Trial register | ALADDIN: evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with pelvic lymph nodes me | Not stated | 3 | - | - |
| NCT04423211 Trial register | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging | currently recruiting participants | - | 2020-06-09 | - |
| NCT04513717 Trial register | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatm | running, but no longer enrolling | - | 2020-08-14 | - |
| NCT05050084 Trial register | Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a | running, but no longer enrolling | - | 2021-09-20 | - |
| NCT04126070 Trial register | Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors | running, but no longer enrolling | - | 2019-10-11 | Posted |
| NCT01786265 Trial register | Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer | running, but no longer enrolling | - | 2013-02-07 | - |
| 2023-507672-52-00 Trial register | SatisfACtion: A Phase I/II, open-label, multi-center study of [225Ac]Ac-PSMA-R2 in men with metastatic hormone sensitive prostate cancer (mHSPC) and in men with | Not stated | 1/2 | - | - |
| NCT07751133 Trial register | Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | not yet recruiting participants | - | 2026-07-25 | - |
| NCT07455903 Trial register | Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT | currently recruiting participants | - | 2026-03-06 | - |
| NCT01542021 Trial register | Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer | completed | - | 2012-03-01 | Posted |
| NCT06379217 Trial register | NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. | running, but no longer enrolling | - | 2024-03-04 | - |
| NCT06378866 Trial register | Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy | currently recruiting participants | - | 2024-04-23 | - |
| NCT06066437 Trial register | NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial | currently recruiting participants | - | 2023-10-04 | - |
| NCT07142967 Trial register | Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II) | currently recruiting participants | - | 2025-08-20 | - |
| NCT02020070 Trial register | Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarel | completed | - | 2013-12-24 | - |
| 2024-511038-11-00 Trial register | A Phase 2, randomized, open-label, dose-finding study of Debio 4228, an extended-release formulation of gonadotropin-releasing hormone antagonist in participant | Not stated | 2 | - | - |
| NCT02346253 Trial register | High-Dose Brachytherapy in Treating Patients With Prostate Cancer | completed | - | 2015-01-26 | - |
| NCT05628363 Trial register | Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With Hig | running, but no longer enrolling | - | 2022-11-16 | Posted |
| NCT07313241 Trial register | Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) | currently recruiting participants | - | 2025-12-16 | - |
| 2023-506365-64-00 Trial register | A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and | Not stated | 3 | - | - |
| NCT06922318 Trial register | The COSMYC Trial (COmbined Suppression of MYC) | currently recruiting participants | - | 2025-04-03 | - |
| NCT05617885 Trial register | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | completed | - | 2022-11-16 | - |
| NCT07477626 Trial register | Radiotherapy After Prostatectomy for Node Positive Prostate Cancer | currently recruiting participants | - | 2026-01-28 | - |
| NCT05873192 Trial register | Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer | currently recruiting participants | - | 2023-05-24 | - |
| 2023-506817-23-01 Trial register | EORTC-2238-GUCG: Intermittent Androgen deprivation Therapy in the era of AR pathway inhibitors; a phase 3 pragmatic randomized trial (DE-ESCALATE) | Not stated | 3 | - | - |
| 2023-507482-26-00 Trial register | PEACE 8: Combination of darolutamide and stereotactic body radiation therapy in patients with castration resistant prostate cancer and oligometastases on functi | Not stated | 3 | - | - |
| NCT02799706 Trial register | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very Hi | running, but no longer enrolling | - | 2016-06-15 | - |
| 2024-520156-22-00 Trial register | A Phase II, randomized, open-label, multi-center study of JSB462 (luxdegalutamide) in combination with abiraterone in adult male patients with metastatic hormon | Not stated | 2 | - | - |
| 2024-518120-68-01 Trial register | Prevention of Sexual Offending with Cognitive Behavioral Therapy Alone Versus Therapy Combined with Testosterone Suppression - the PREVENT-MED randomized clinic | Not stated | 2 | - | - |
| NCT03361735 Trial register | Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | running, but no longer enrolling | - | 2017-12-05 | Posted |
| NCT04787744 Trial register | Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Can | currently recruiting participants | - | 2021-03-09 | - |
| NCT05839119 Trial register | Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant | terminated before completion | - | 2023-05-03 | - |
| NCT06734130 Trial register | Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer | running, but no longer enrolling | - | 2024-12-11 | - |
| NCT03947151 Trial register | Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility | completed | - | 2019-05-13 | - |
| 2023-507970-42-00 Trial register | PSMAddition: An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard | Not stated | 3 | - | - |
| NCT06282588 Trial register | Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers | currently recruiting participants | - | 2024-01-19 | - |
| NCT07142551 Trial register | Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response | currently recruiting participants | - | 2025-08-19 | - |
| NCT00936390 Trial register | Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer | completed | - | 2009-07-08 | Posted |
| 2024-513450-30-00 Trial register | EORTC protocol 1414-ROG-GUCG: Phase IIIb randomized trial comparing irradiation plus long-term adjuvant androgen deprivation with GnRH antagonist versus GnRH ag | Not stated | 3 | - | - |
| NCT04455750 Trial register | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-De | running, but no longer enrolling | - | 2020-07-02 | - |
| NCT07389174 Trial register | Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer | not yet recruiting participants | - | 2025-12-28 | - |
| NCT07389187 Trial register | Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | not yet recruiting participants | - | 2025-12-28 | - |
| NCT05701007 Trial register | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | completed | - | 2023-01-26 | Posted |
| NCT04734730 Trial register | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer | currently recruiting participants | - | 2021-02-02 | - |
| NCT06397703 Trial register | ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer | currently recruiting participants | - | 2024-05-03 | - |
| NCT06059118 Trial register | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | currently recruiting participants | - | 2023-09-15 | - |
| NCT01746849 Trial register | Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cel | running, but no longer enrolling | - | 2012-12-11 | - |
| NCT06531499 Trial register | A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Cast | currently recruiting participants | - | 2024-06-18 | - |
| NCT05241860 Trial register | Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) | running, but no longer enrolling | - | 2022-01-31 | Posted |
| NCT00117286 Trial register | Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer | completed | - | 2005-07-06 | Posted |
| NCT03009981 Trial register | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | completed | - | 2017-01-03 | - |
| NCT04034095 Trial register | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | completed | - | 2019-07-16 | - |
| 2023-503254-12-00 Trial register | A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and | Not stated | 3 | - | - |
| NCT07268794 Trial register | CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer | not yet recruiting participants | - | 2025-11-16 | - |
| NCT05189457 Trial register | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | running, but no longer enrolling | - | 2021-12-29 | - |
| NCT03069937 Trial register | Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. | completed | - | 2017-03-03 | Posted |
| NCT06528210 Trial register | Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer | withdrawn before enrolling anyone | - | 2024-05-30 | - |
| NCT02972060 Trial register | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer | running, but no longer enrolling | - | 2016-11-21 | - |
| NCT03678025 Trial register | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | currently recruiting participants | - | 2018-09-19 | - |
| NCT01990196 Trial register | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | running, but no longer enrolling | - | 2013-11-21 | - |
| NCT04666129 Trial register | Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | completed | - | 2020-12-07 | - |
| NCT04391556 Trial register | Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma | completed | - | 2020-04-23 | - |
| NCT04301414 Trial register | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer | completed | - | 2020-03-10 | - |
| 2024-510840-30-00 Trial register | EORTC-1532-GUCG: A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in | Not stated | 2 | - | - |
| NCT02278185 Trial register | Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | completed | - | 2014-10-29 | Posted |
| NCT03703778 Trial register | Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) | running, but no longer enrolling | - | 2018-03-12 | - |
| NCT03689699 Trial register | Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) | running, but no longer enrolling | - | 2018-09-28 | Posted |
| NCT03951831 Trial register | REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer | running, but no longer enrolling | - | 2019-05-15 | - |
| NCT01220869 Trial register | A Study of Degarelix in Taiwanese Patients With Prostate Cancer | completed | - | 2010-10-14 | Posted |
| NCT05057546 Trial register | Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) | running, but no longer enrolling | - | 2021-09-16 | - |
| NCT05917860 Trial register | Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer | running, but no longer enrolling | - | 2023-06-26 | - |
| 2024-519516-14-01 Trial register | The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic prostate cancer | Not stated | 2 | - | - |
| NCT01994239 Trial register | Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy | running, but no longer enrolling | - | 2013-11-25 | - |
| 2023-503676-25-01 Trial register | Progression under Olaparib: a randomized phaSE II trIal with docetaxel or carboplatin-docetaxel DOublet in mCRPC patieNts | Not stated | 2 | - | - |
| NCT01261572 Trial register | Study to Find Maintenance Dose for Periodic Administration of ASP3550 | completed | - | 2010-12-16 | - |
| NCT01964170 Trial register | A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer | completed | - | 2013-10-17 | - |
| NCT06218667 Trial register | A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer | withdrawn before enrolling anyone | - | 2024-01-23 | - |
| NCT05181800 Trial register | FIRMAGON® Intensive Drug Monitoring | completed | - | 2022-01-06 | Posted |
| NCT03056638 Trial register | Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer | terminated before completion | - | 2017-02-17 | Posted |
| NCT03080116 Trial register | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy | last verified some time ago; the register no longer confirms its status | - | 2017-03-15 | - |
| NCT06264882 Trial register | Cardiometabolic Consequences of the Loss of Ovarian Function | currently recruiting participants | - | 2024-02-20 | - |
| NCT02478775 Trial register | Dysregulation of FSH in Obesity: Functional and Statistical Analysis | completed | - | 2015-06-23 | Posted |
| NCT03358563 Trial register | Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | completed | - | 2017-11-30 | - |
| NCT01851018 Trial register | Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment | last verified some time ago; the register no longer confirms its status | - | 2012-11-27 | - |
| NCT03311555 Trial register | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical P | completed | - | 2017-09-26 | Posted |
| NCT01712763 Trial register | Degarelix in the Treatment of Endometriosis Recurrence | completed | - | 2012-10-24 | - |
| NCT05149131 Trial register | A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer | completed | - | 2021-11-25 | - |
| NCT03899077 Trial register | Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP | last verified some time ago; the register no longer confirms its status | - | 2019-04-02 | - |
| NCT04176081 Trial register | Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer | not yet recruiting participants | - | 2019-11-25 | - |
| NCT04043520 Trial register | Bioenergetic Effects of Aging and Menopause (BEAM) | currently recruiting participants | - | 2019-06-25 | - |
| NCT00818623 Trial register | Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients | completed | - | 2009-01-08 | Posted |
| NCT00819156 Trial register | Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer | completed | - | 2009-01-08 | Posted |
| NCT00819247 Trial register | The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer | completed | - | 2009-01-08 | Posted |
| NCT00930319 Trial register | Effectiveness and Safety of Firmagon® | completed | - | 2009-06-29 | - |
| NCT01377389 Trial register | Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | terminated before completion | - | 2011-06-21 | Posted |
| NCT06001619 Trial register | Prostate Medication, Metabolism and Gut Microbiota | currently recruiting participants | - | 2023-04-14 | - |
| NCT04897958 Trial register | Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data | completed | - | 2021-05-24 | - |
| NCT02015871 Trial register | An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer | completed | - | 2013-12-19 | - |
| 2022-502067-38-00 Trial register | Effect of neoadjuvant Degarelix on MRI-guided transurethral ultrasound ablation in patients with intermediate-risk prostate cancer: A pilot study | Not stated | 1 | - | - |
| NCT04282876 Trial register | Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer | last verified some time ago; the register no longer confirms its status | - | 2020-02-25 | - |
| NCT02663908 Trial register | A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease | terminated before completion | - | 2016-01-26 | Posted |
| NCT04397718 Trial register | Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization | completed | - | 2020-05-21 | Posted |
| NCT05212857 Trial register | Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2022-01-28 | - |
| NCT02849990 Trial register | A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy | completed | - | 2016-07-29 | Posted |
| NCT02726009 Trial register | A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | completed | - | 2016-04-01 | - |
| NCT01751451 Trial register | 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Ri | completed | - | 2012-12-18 | Posted |
| NCT02489357 Trial register | Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer | completed | - | 2015-07-03 | Posted |
| NCT04248621 Trial register | Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients | last verified some time ago; the register no longer confirms its status | - | 2020-01-30 | - |
| NCT03112226 Trial register | Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function | completed | - | 2017-04-07 | - |
| NCT03876912 Trial register | The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer | last verified some time ago; the register no longer confirms its status | - | 2019-03-14 | - |
| NCT04585932 Trial register | Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study | withdrawn before enrolling anyone | - | 2020-10-14 | - |
| NCT00303784 Trial register | Prostate Adenocarcinoma TransCutaneous Hormones | last verified some time ago; the register no longer confirms its status | - | 2006-03-17 | - |
| NCT03240159 Trial register | Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix | last verified some time ago; the register no longer confirms its status | - | 2017-08-07 | - |
| NCT03861715 Trial register | Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors. | last verified some time ago; the register no longer confirms its status | - | 2019-03-01 | - |
| NCT03877185 Trial register | A New Revolutionary 3-Injection- Protocol in Infertile Women | last verified some time ago; the register no longer confirms its status | - | 2019-03-14 | - |
| NCT02472275 Trial register | PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer | completed | - | 2015-06-11 | - |
| NCT01545882 Trial register | A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer | terminated before completion | - | 2012-03-07 | - |
| NCT01710098 Trial register | Treatment of Prostate Cancer With Firmagon® | completed | - | 2012-10-18 | - |
| NCT01446991 Trial register | Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy | completed | - | 2011-10-05 | - |
| NCT04134130 Trial register | The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer | completed | - | 2019-10-22 | - |
| NCT04182594 Trial register | Cardiovascular Events in GnRH Agonist vs. Antagonist | last verified some time ago; the register no longer confirms its status | - | 2019-12-02 | - |
| NCT01512472 Trial register | Firmagon (Degarelix) Intermittent Therapy | terminated before completion | - | 2012-01-19 | - |
| NCT02324998 Trial register | Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy | completed | - | 2014-12-24 | - |
| NCT02234089 Trial register | Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasi | completed | - | 2014-09-09 | - |
| NCT01234350 Trial register | A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON | completed | - | 2010-11-03 | Posted |
| NCT02886598 Trial register | Safety and Efficacy of Firmagon® (Degarelix) for Injection | completed | - | 2016-09-01 | - |
| NCT02475057 Trial register | Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists | completed | - | 2015-06-18 | - |
| NCT01862835 Trial register | Impact of Estradiol Addback | completed | - | 2013-05-27 | - |
| NCT01696877 Trial register | A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer | completed | - | 2012-10-01 | Posted |
| NCT03193645 Trial register | Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix | completed | - | 2017-06-21 | - |
| NCT01731912 Trial register | Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer | completed | - | 2012-11-22 | Posted |
| NCT02560051 Trial register | Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | terminated before completion | - | 2015-09-25 | Posted |
| NCT02494713 Trial register | Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | terminated before completion | - | 2015-07-10 | Posted |
| NCT01861236 Trial register | Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina | completed | - | 2013-05-23 | - |
| NCT02229253 Trial register | Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer | completed | - | 2014-09-01 | - |
| NCT02468284 Trial register | Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer | completed | - | 2015-06-10 | - |
| NCT02526784 Trial register | A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer | completed | - | 2015-08-18 | - |
| NCT03202381 Trial register | Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix | last verified some time ago; the register no longer confirms its status | - | 2017-06-28 | - |
| NCT02135445 Trial register | Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer | completed | - | 2014-05-12 | Posted |
| NCT01366053 Trial register | Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists | completed | - | 2011-06-03 | - |
| NCT00928434 Trial register | A Study of Degarelix in Patients With Prostate Cancer | completed | - | 2009-06-26 | Posted |
| NCT01709942 Trial register | Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) | completed | - | 2012-10-18 | - |
| NCT01674270 Trial register | Degarelix Neo-Adjuvant Radical Prostatectomy Trial | completed | - | 2012-08-28 | - |
| NCT01215526 Trial register | A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer | completed | - | 2010-10-05 | - |
| NCT01744366 Trial register | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population | completed | - | 2012-12-06 | - |
| NCT00947882 Trial register | A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) | completed | - | 2009-07-28 | Posted |
| NCT01242748 Trial register | A Degarelix Trial in Patients With Prostate Cancer | terminated before completion | - | 2010-11-17 | Posted |
| NCT00527488 Trial register | Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. | completed | - | 2007-09-11 | Posted |
| NCT00215683 Trial register | An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer | completed | - | 2005-09-22 | Posted |
| NCT02159690 Trial register | A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy | withdrawn before enrolling anyone | - | 2014-06-10 | - |
| NCT01852864 Trial register | Degarelix Before Radical Prostatectomy | last verified some time ago; the register no longer confirms its status | - | 2013-05-14 | - |
| NCT00568516 Trial register | Phase II Study of ASP3550 in Patients With Prostate Cancer | completed | - | 2007-12-05 | - |
| NCT00801242 Trial register | Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer | completed | - | 2008-12-03 | Posted |
| NCT01729676 Trial register | Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation | completed | - | 2012-11-20 | - |
| NCT00946920 Trial register | A Trial of Degarelix in Patients With Prostate Cancer | completed | - | 2009-07-27 | Posted |
| NCT02084940 Trial register | Long Acting GnRH Antagonist in PCOS Women Undergoing IVF | last verified some time ago; the register no longer confirms its status | - | 2014-03-12 | - |
| NCT01491971 Trial register | Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer | completed | - | 2011-12-14 | - |
| NCT00884273 Trial register | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | - | 2009-04-20 | Posted |
| NCT00831233 Trial register | Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer | terminated before completion | - | 2009-01-28 | Posted |
| NCT01215513 Trial register | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | completed | - | 2010-10-06 | Posted |
| NCT00451958 Trial register | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | - | 2007-03-26 | Posted |
| NCT01344564 Trial register | Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide | completed | - | 2011-04-29 | - |
| NCT01071915 Trial register | Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer | completed | - | 2010-02-19 | Posted |
| NCT00738673 Trial register | Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer | completed | - | 2008-08-20 | Posted |
| NCT00967018 Trial register | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | - | 2009-08-27 | Posted |
| NCT00295750 Trial register | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | - | 2006-02-24 | Posted |
| NCT00833248 Trial register | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | - | 2009-02-02 | Posted |
| NCT00116779 Trial register | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | - | 2005-07-01 | Posted |
| NCT00434122 Trial register | Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix | completed | - | 2007-02-12 | Posted |
| NCT00117312 Trial register | Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients | terminated before completion | - | 2005-07-06 | Posted |
| NCT00117949 Trial register | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 | completed | - | 2005-07-11 | Posted |
| NCT00215657 Trial register | Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients | terminated before completion | - | 2005-09-22 | Posted |
| NCT00245466 Trial register | Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients | terminated before completion | - | 2005-10-28 | Posted |
| NCT00468286 Trial register | Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy | completed | - | 2007-05-02 | Posted |
| NCT00728533 Trial register | Open-Label, Randomised Parallel-Group Study | withdrawn before enrolling anyone | - | 2008-08-06 | - |
| NCT00268892 Trial register | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | - | 2005-12-23 | Posted |
| NCT00116753 Trial register | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | - | 2005-07-01 | Posted |
Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.